Published in Br J Pharmacol on March 01, 2005
Imaging the neural circuitry and chemical control of aggressive motivation. BMC Neurosci (2008) 1.38
Long-lasting behavioral effects and recognition memory deficit induced by chronic mild stress in mice: effect of antidepressant treatment. Psychopharmacology (Berl) (2008) 1.21
Modulation of serotonin transporter function during fetal development causes dilated heart cardiomyopathy and lifelong behavioral abnormalities. PLoS One (2008) 1.10
Deficient serotonin neurotransmission and depression-like serotonin biomarker alterations in tryptophan hydroxylase 2 (Tph2) loss-of-function mice. Mol Psychiatry (2011) 1.10
Behavioral disinhibition and reduced anxiety-like behaviors in monoamine oxidase B-deficient mice. Neuropsychopharmacology (2009) 0.99
Paradoxical anxiogenic response of juvenile mice to fluoxetine. Neuropsychopharmacology (2009) 0.99
Serotonin transporter genotype interacts with paroxetine plasma levels to influence depression treatment response in geriatric patients. J Psychiatry Neurosci (2008) 0.95
Flow cytometric analysis of BrdU incorporation as a high-throughput method for measuring adult neurogenesis in the mouse. J Pharmacol Toxicol Methods (2008) 0.95
Neurochemical responses to antidepressants in the prefrontal cortex of mice and their efficacy in preclinical models of anxiety-like and depression-like behavior: a comparative and correlational study. Psychopharmacology (Berl) (2008) 0.92
The interaction of escitalopram and R-citalopram at the human serotonin transporter investigated in the mouse. Psychopharmacology (Berl) (2014) 0.89
Association of changes in norepinephrine and serotonin transporter expression with the long-term behavioral effects of antidepressant drugs. Neuropsychopharmacology (2008) 0.88
Prediction of clinical response based on pharmacokinetic/pharmacodynamic models of 5-hydroxytryptamine reuptake inhibitors in mice. Br J Pharmacol (2008) 0.86
Relationship between cerebral sigma-1 receptor occupancy and attenuation of cocaine's motor stimulatory effects in mice by PD144418. J Pharmacol Exp Ther (2014) 0.83
The 5-HT7 receptor influences stereotypic behavior in a model of obsessive-compulsive disorder. Neurosci Lett (2007) 0.83
Selective serotonin reuptake inhibitors and raft inhibitors shorten the period of Period1-driven circadian bioluminescence rhythms in rat-1 fibroblasts. Life Sci (2008) 0.83
Influence of chronic amphetamine treatment and acute withdrawal on serotonin synthesis and clearance mechanisms in the rat ventral hippocampus. Eur J Neurosci (2012) 0.82
RNAi-mediated serotonin transporter suppression rapidly increases serotonergic neurotransmission and hippocampal neurogenesis. Transl Psychiatry (2013) 0.81
Effects of mood stabilizers on marble-burying behavior in mice: involvement of GABAergic system. Psychopharmacology (Berl) (2012) 0.80
Genetic Pharmacotherapy as an Early CNS Drug Development Strategy: Testing Glutaminase Inhibition for Schizophrenia Treatment in Adult Mice. Front Syst Neurosci (2016) 0.79
Ether modifications to 1-[2-(3,4-dimethoxyphenyl)ethyl]-4-(3-phenylpropyl)piperazine (SA4503): effects on binding affinity and selectivity for sigma receptors and monoamine transporters. Bioorg Med Chem (2014) 0.78
Sigma receptors [σRs]: biology in normal and diseased states. J Recept Signal Transduct Res (2015) 0.78
Robust presynaptic serotonin 5-HT(1B) receptor inhibition of the striatonigral output and its sensitization by chronic fluoxetine treatment. J Neurophysiol (2015) 0.78
Ethanol self-administration in mice under a second-order schedule. Alcohol (2015) 0.78
Allergic fetal priming leads to developmental, behavioral and neurobiological changes in mice. Transl Psychiatry (2015) 0.77
Active metabolites as antidepressant drugs: the role of norquetiapine in the mechanism of action of quetiapine in the treatment of mood disorders. Front Psychiatry (2013) 0.77
Tabernaemontana divaricata leaves extract exacerbate burying behavior in mice. Avicenna J Phytomed (2015) 0.75
Antidepressant effects of combination of brexpiprazole and fluoxetine on depression-like behavior and dendritic changes in mice after inflammation. Psychopharmacology (Berl) (2016) 0.75
Pharmacokinetic-pharmacodynamic modelling of fluvoxamine 5-HT transporter occupancy in rat frontal cortex. Br J Pharmacol (2008) 0.75
Tactics for preclinical validation of receptor-binding radiotracers. Nucl Med Biol (2016) 0.75
Comparative effects of sertraline, haloperidol or olanzapine treatments on ketamine-induced changes in mouse behaviours. Metab Brain Dis (2017) 0.75
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur J Pharmacol (1978) 4.76
A graphic method for the determination and presentation of binding parameters in a complex system. Anal Biochem (1967) 4.32
Efficacy of drug treatment in obsessive-compulsive disorder. A meta-analytic review. Br J Psychiatry (1995) 2.55
Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites. J Pharmacol Exp Ther (1997) 2.16
Evaluation of marble-burying behavior as a model of anxiety. Pharmacol Biochem Behav (1991) 2.04
Prozac (fluoxetine, Lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: twenty years since its first publication. Life Sci (1995) 1.92
Pharmacokinetics of selective serotonin reuptake inhibitors. Pharmacol Ther (2000) 1.87
5-HT1A-receptor subtype mediates the effect of fluvoxamine, a selective serotonin reuptake inhibitor, on marble-burying behavior in mice. Jpn J Pharmacol (1995) 1.15
Acute uptake inhibition increases extracellular serotonin in the rat forebrain. J Pharmacol Exp Ther (1993) 1.11
How do antidepressants work? Prospects for genetic analysis of drug mechanisms. Cell (1999) 1.05
Influence of dose and route of administration on the kinetics of fluoxetine and its metabolite norfluoxetine in the rat. Psychopharmacology (Berl) (1990) 1.03
Metabolism and pharmacokinetics of selective serotonin reuptake inhibitors. Cell Mol Neurobiol (1999) 0.96
Relationship of paroxetine disposition to metoprolol metabolic ratio and CYP2D6*10 genotype of Korean subjects. Clin Pharmacol Ther (2000) 0.96
Effects of single and repeated oral administration of fluvoxamine on extracellular serotonin in the median raphe nucleus and dorsal hippocampus of the rat. Neuropharmacology (1995) 0.94
In vivo demonstration of alpha(1A)-adrenoceptor subtype selectivity of KMD-3213 in rat tissues. J Pharmacol Exp Ther (2001) 0.92
Fluvoxamine. An updated review of its use in the management of adults with anxiety disorders. Drugs (2000) 0.91
Effects of acute and chronic tianeptine administration on serotonin outflow in rats: comparison with paroxetine by using in vivo microdialysis. Eur J Pharmacol (2000) 0.89
Characterization of [3H]paroxetine binding to rat cortical membranes. Eur J Pharmacol (1985) 0.88
Routine measurement of fluoxetine and norfluoxetine by high-performance liquid chromatography with ultraviolet detection in patients under concomitant treatment with tricyclic antidepressants. Ther Drug Monit (1998) 0.86
Characterization of alpha-1 adrenergic receptors in the heart using [3H]WB4101: effect of 6-hydroxydopamine treatment. J Pharmacol Exp Ther (1980) 0.86
Brain nicotinic acetylcholine receptors. Biochemical characterization by neosurugatoxin. Mol Pharmacol (1985) 0.85
In vivo receptor binding of benidipine and amlodipine in mesenteric arteries and other tissues of spontaneously hypertensive rats. Life Sci (2002) 0.81
Drug concentrations in mouse brain at pharmacologically active doses of fluoxetine enantiomers. Biochem Pharmacol (1993) 0.78
Receptor occupancy in myocardium, adrenal cortex, and brain by TH-142177, a novel AT1 receptor antagonist in rats, in relation to its plasma concentration and hypotensive effect. Pharm Res (1998) 0.78
Relationship between body mass index and gray matter volume in 1,428 healthy individuals. Obesity (Silver Spring) (2008) 2.30
Interaction between amlodipine and simvastatin in patients with hypercholesterolemia and hypertension. Hypertens Res (2005) 1.54
Effects of calcineurin inhibitors on pharmacokinetics of mycophenolic acid and its glucuronide metabolite during the maintenance period following renal transplantation. Biol Pharm Bull (2006) 1.48
Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications. Int J Pharm (2011) 1.38
Early gastric cancer with Krukenberg tumor and review of cases of intramucosal gastric cancers with Krukenberg tumor. J Gastroenterol (2003) 1.36
Characterization and distribution of bone marrow-derived cells in mouse cornea. Invest Ophthalmol Vis Sci (2005) 1.33
The use of frozen autogenous bone flaps in delayed cranioplasty revisited. Neurosurgery (2003) 1.29
Cutaneous angiolipoleiomyoma. J Am Acad Dermatol (2006) 1.23
Male elderly subthreshold depression patients have smaller volume of medial part of prefrontal cortex and precentral gyrus compared with age-matched normal subjects: a voxel-based morphometry. J Affect Disord (2005) 1.11
Bullous Systemic Lupus Erythematosus as an Initial Manifestation of SLE. J Dermatol (2005) 1.07
Collagen-phosphorylcholine interpenetrating network hydrogels as corneal substitutes. Biomaterials (2008) 1.06
Prolonged anti-inflammatory action of DL-lactide/glycolide copolymer nanospheres containing betamethasone sodium phosphate for an intra-articular delivery system in antigen-induced arthritic rabbit. Pharm Res (2002) 1.06
Right frontopolar cortex activity correlates with reliability of retrospective rating of confidence in short-term recognition memory performance. Neurosci Res (2010) 1.05
Targeting Id1 and Id3 inhibits peritoneal metastasis of gastric cancer. Cancer Sci (2005) 1.05
Pharmacological synergism between cannabinoids and paclitaxel in gastric cancer cell lines. J Surg Res (2008) 1.04
Cortical activation in the processing of passive sentences in L1 and L2: an fMRI study. Neuroimage (2005) 1.04
Quantitative analysis of binding parameters of [3H]N-methylscopolamine in central nervous system of muscarinic acetylcholine receptor knockout mice. Brain Res Mol Brain Res (2005) 1.02
Tissue-engineered recombinant human collagen-based corneal substitutes for implantation: performance of type I versus type III collagen. Invest Ophthalmol Vis Sci (2008) 1.00
Role of positively charged amino acids in the M2D transmembrane helix of Ktr/Trk/HKT type cation transporters. Channels (Austin) (2007) 0.97
Capsular tension ring use in a patient with congenital coloboma of the lens. J Cataract Refract Surg (2004) 0.97
Cell cycle phenotype-based optimization of G2-abrogating peptides yields CBP501 with a unique mechanism of action at the G2 checkpoint. Mol Cancer Ther (2007) 0.96
Formulation design and photochemical studies on nanocrystal solid dispersion of curcumin with improved oral bioavailability. J Pharm Sci (2010) 0.94
Involvement of cathepsin B in the processing and secretion of interleukin-1beta in chromogranin A-stimulated microglia. Glia (2010) 0.94
Cordycepin (3'-deoxyadenosine) inhibits the growth of B16-BL6 mouse melanoma cells through the stimulation of adenosine A3 receptor followed by glycogen synthase kinase-3beta activation and cyclin D1 suppression. Naunyn Schmiedebergs Arch Pharmacol (2007) 0.93
Human muscarinic receptor binding characteristics of antimuscarinic agents to treat overactive bladder. J Urol (2006) 0.92
Effects of the serotonin and noradrenaline reuptake inhibitor (SNRI) milnacipran on marble burying behavior in mice. Biol Pharm Bull (2007) 0.92
Cortical areas related to performance of WAIS Digit Symbol Test: a functional imaging study. Neurosci Lett (2009) 0.92
Serum cystatin C as a better marker of vancomycin clearance than serum creatinine in elderly patients. Clin Biochem (2007) 0.92
Establishment of monoclonal antibodies against the extracellular domain that block binding of NMO-IgG to AQP4. J Neuroimmunol (2013) 0.91
Late Jurassic ocean anoxic event: evidence from voluminous sulphide deposition and preservation in the Panthalassa. Sci Rep (2013) 0.91
Conversion of aquaporin 6 from an anion channel to a water-selective channel by a single amino acid substitution. Proc Natl Acad Sci U S A (2005) 0.91
Pilot study of anti-angiogenic vaccine using fixed whole endothelium in patients with progressive malignancy after failure of conventional therapy. Eur J Cancer (2007) 0.90
A possible mechanism for decrease in serum thyroxine level by polychlorinated biphenyls in Wistar and Gunn rats. Toxicol Sci (2004) 0.90
Intraperitoneal administration of paclitaxel solubilized with poly(2-methacryloxyethyl phosphorylcholine-co n-butyl methacrylate) for peritoneal dissemination of gastric cancer. Cancer Sci (2009) 0.90
Muscarinic receptor binding, plasma concentration and inhibition of salivation after oral administration of a novel antimuscarinic agent, solifenacin succinate in mice. Br J Pharmacol (2005) 0.89
Bisbenzylisoquinoline Alkaloids from Nelumbo nucifera. Chem Pharm Bull (Tokyo) (2011) 0.89
Effects of Ginkgo biloba extract on pharmacokinetics and pharmacodynamics of tolbutamide and midazolam in healthy volunteers. J Clin Pharmacol (2006) 0.89
In vivo demonstration of M3 muscarinic receptor subtype selectivity of darifenacin in mice. Life Sci (2006) 0.89
CD11b-mediated migratory property of peripheral blood B cells. J Allergy Clin Immunol (2005) 0.89
Internalization of basic fibroblast growth factor at the mouse blood-brain barrier involves perlecan, a heparan sulfate proteoglycan. J Neurochem (2002) 0.88
Mouse strain differences in immobility and sensitivity to fluvoxamine and desipramine in the forced swimming test: analysis of serotonin and noradrenaline transporter binding. Eur J Pharmacol (2008) 0.88
Functional analysis of muscarinic acetylcholine receptors using knockout mice. Life Sci (2004) 0.88
Activation of muscarinic M-1 cholinoceptors by curcumin to increase contractility in urinary bladder isolated from Wistar rats. Neurosci Lett (2010) 0.88
VAT-1 is a novel pathogenic factor of progressive benign prostatic hyperplasia. Prostate (2011) 0.88
Effects of green tea catechins on cytochrome P450 2B6, 2C8, 2C19, 2D6 and 3A activities in human liver and intestinal microsomes. Drug Metab Pharmacokinet (2012) 0.87
Hepatic UDP-glucuronosyltransferases responsible for glucuronidation of thyroxine in humans. Drug Metab Dispos (2007) 0.87
Antinociceptive effects of St. John's wort, Harpagophytum procumbens extract and Grape seed proanthocyanidins extract in mice. Biol Pharm Bull (2008) 0.87
Advantages for transdermal over oral oxybutynin to treat overactive bladder: Muscarinic receptor binding, plasma drug concentration, and salivary secretion. J Pharmacol Exp Ther (2005) 0.87
Inhibition of NMDA-induced outward currents by interleukin-1beta in hippocampal neurons. Biochem Biophys Res Commun (2008) 0.87
Establishment of a new animal model of focal subretinal fibrosis that resembles disciform lesion in advanced age-related macular degeneration. Invest Ophthalmol Vis Sci (2011) 0.87
Involvement of dopamine receptors in the anti-immobility effects of dopamine re-uptake inhibitors in the forced swimming test. Eur J Pharmacol (2004) 0.86
Sulforaphane induces inhibition of human umbilical vein endothelial cells proliferation by apoptosis. Angiogenesis (2006) 0.86
Characterization of muscarinic receptor binding and inhibition of salivation after oral administration of tolterodine in mice. Eur J Pharmacol (2005) 0.86
Mouse synovial mesenchymal stem cells increase in yield with knee inflammation. J Orthop Res (2014) 0.86
Structure-activity relationships of receptor binding of 1,4-dihydropyridine derivatives. Biol Pharm Bull (2008) 0.86
Coleus forskohlii extract induces hepatic cytochrome P450 enzymes in mice. Food Chem Toxicol (2011) 0.85
Reactions of a platinum(III) dimeric complex with alkynes in water: novel approach to alpha-aminoketone, alpha-iminoketone, and alpha,beta-diimine via ketonyl-Pt(III) dinuclear complexes. J Am Chem Soc (2004) 0.85
Effects of dosing interval on the pharmacokinetic and pharmacodynamic interactions between the oral adsorbent AST-120 and triazolam in humans. Eur J Clin Pharmacol (2012) 0.85
[Effects of processing and cooking on the levels of pesticide residues in rice samples]. Shokuhin Eiseigaku Zasshi (2008) 0.85
In vitro and in vivo characterization on amorphous solid dispersion of cyclosporine A for inhalation therapy. J Control Release (2009) 0.85
Isolation and pharmacological characterization of fatty acids from saw palmetto extract. Anal Sci (2009) 0.85
Using comparative anatomy in the axotomy model to identify distinct roles for microglia and astrocytes in synaptic stripping. Neuron Glia Biol (2012) 0.85
Acid sphingomyelinase activation requires caspase-8 but not p53 nor reactive oxygen species during Fas-induced apoptosis in human glioma cells. Exp Cell Res (2002) 0.85
Effects of continuous administration of paroxetine on ligand binding site and expression of serotonin transporter protein in mouse brain. Brain Res (2005) 0.85
Selective protection of curcumin against carbon tetrachloride-induced inactivation of hepatic cytochrome P450 isozymes in rats. Life Sci (2005) 0.85
Prediction of alpha1-adrenoceptor occupancy in the human prostate from plasma concentrations of silodosin, tamsulosin and terazosin to treat urinary obstruction in benign prostatic hyperplasia. Biol Pharm Bull (2007) 0.84
Ginkgo biloba extract attenuates warfarin-mediated anticoagulation through induction of hepatic cytochrome P450 enzymes by bilobalide in mice. Phytomedicine (2011) 0.84
Pharmacological effects of Hachi-mi-jio-gan extract (Harncare) on the contractile response and on pharmacologically relevant receptors in the rat bladder. Yakugaku Zasshi (2009) 0.84
Effects of extracts and neferine from the embryo of Nelumbo nucifera seeds on the central nervous system. Phytomedicine (2008) 0.84
Liposomal formulations of glucagon-like peptide-1: improved bioavailability and anti-diabetic effect. Int J Pharm (2009) 0.84
Pharmacokinetics of arsenic species in Japanese patients with relapsed or refractory acute promyelocytic leukemia treated with arsenic trioxide. Cancer Chemother Pharmacol (2006) 0.84
Blood-brain permeability of [3H]-(3-methyl-His2)thyrotropin-releasing hormone (MeTRH) in mice: effects of TRH and its analogues. Drug Metab Pharmacokinet (2003) 0.84
Hepatic cytochrome P450 mediates interaction between warfarin and Coleus forskohlii extract in vivo and in vitro. J Pharm Pharmacol (2012) 0.84
Simultaneous LC-MS/MS analysis of the plasma concentrations of a cocktail of 5 cytochrome P450 substrate drugs and their metabolites. Biol Pharm Bull (2014) 0.84
Noninvasive evaluation of brain muscarinic receptor occupancy of oxybutynin, darifenacin and imidafenacin in rats by positron emission tomography. Life Sci (2010) 0.84
Epigallocatechin gallate affects human dendritic cell differentiation and maturation. J Allergy Clin Immunol (2007) 0.83
Bioactive analogues and drug delivery systems of vasoactive intestinal peptide (VIP) for the treatment of asthma/COPD. Peptides (2007) 0.83
Natural vanadium-containing Mt. Fuji ground water improves hypo-activity of liver insulin receptor in Goto-Kakisaki rats. Mol Cell Biochem (2004) 0.83
Quantitative analysis of the loss of muscarinic receptors in various peripheral tissues in M1-M5 receptor single knockout mice. Br J Pharmacol (2009) 0.83
Improved dissolution and pharmacokinetic behavior of cyclosporine A using high-energy amorphous solid dispersion approach. Int J Pharm (2010) 0.83
Effects of dietary ingredients on function and expression of P-glycoprotein in human intestinal epithelial cells. Biol Pharm Bull (2010) 0.83
Apoptosis induction by p38 MAPK inhibitor in human colon cancer cells. Hepatogastroenterology (2008) 0.83
Binding activities by propiverine and its N-oxide metabolites of L-type calcium channel antagonist receptors in the rat bladder and brain. Life Sci (2007) 0.82
Establishment and intra-/inter-laboratory validation of a standard protocol of reactive oxygen species assay for chemical photosafety evaluation. J Appl Toxicol (2012) 0.82
Antidepressant-like effects of neferine in the forced swimming test involve the serotonin1A (5-HT1A) receptor in mice. Eur J Pharmacol (2010) 0.82
Induction and recovery of hepatic drug metabolizing enzymes in rats treated with Ginkgo biloba extract. Food Chem Toxicol (2004) 0.82
Physicochemical and pharmacokinetic characterization of water-soluble Coenzyme Q(10) formulations. Int J Pharm (2008) 0.82
Plaunotol and geranylgeraniol induce caspase-mediated apoptosis in colon cancer. J Surg Res (2008) 0.82
In vivo quantitative autoradiographic analysis of brain muscarinic receptor occupancy by antimuscarinic agents for overactive bladder treatment. J Pharmacol Exp Ther (2008) 0.82